Oral Iloprost Improves Endobronchial Dysplasia in Former Smokers

There are no established chemopreventive agents for lung cancer, the leading cause of cancer death in the United States. Prostacyclin levels are low in lung cancer and supplementation prevents lung cancer in preclinical models. We carried out a multicenter double-blind, randomized, phase II placebo-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Keith, Robert L., Blatchford, Patrick J., Kittelson, John, Minna, John D., Kelly, Karen, Massion, Pierre P., Franklin, Wilbur A., Mao, Jenny, Wilson, David O., Merrick, Daniel T., Hirsch, Fred R., Kennedy, Timothy C., Bunn, Paul A., Geraci, Mark W., Miller, York E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251330/
https://ncbi.nlm.nih.gov/pubmed/21636546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-11-0057
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak